Assembly Biosciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $6,845 | $8,533 | $5,785 | $7,163 |
Gross Profit | 6,845 | 8,501 | 5,753 | 7,079 |
EBITDA | -10,923 | -12,171 | -10,697 | -12,467 |
EBIT | -10,956 | -12,203 | -10,729 | -12,551 |
Net Income | -9,613 | -11,152 | -9,077 | -10,962 |
Net Change In Cash | 6,845 | 8,533 | 5,785 | 7,163 |
Free Cash Flow | -15,244 | -17,116 | -18,378 | 73,576 |
Cash | 28,452 | 19,208 | 18,749 | 19,841 |
Basic Shares | 6,351 | 5,642 | 5,483 | 5,482 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $7,163 | $0 | $6,254 | $79,105 |
Gross Profit | -41,737 | -498 | 5,788 | 79,003 |
EBITDA | -64,196 | -93,616 | -91,932 | -64,776 |
EBIT | -64,646 | -94,114 | -92,398 | -65,467 |
Net Income | -61,228 | -92,070 | -129,855 | -59,528 |
Net Change In Cash | 7,163 | 0 | 6,254 | 79,105 |
Cost of Revenue | 6,791 | 12,712 | ||
Free Cash Flow | 22,488 | -84,565 | -96,492 | -65,177 |
Cash | 19,841 | 52,418 | 45,627 | 59,444 |
Basic Shares | 4,577 | 4,034 | 46,846 | 39,679 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.51 |
2024-06-30 | -$2.05 |
2024-03-31 | -$1.66 |
2023-12-31 | -$2.15 |
